港股詳情

本页面由TTMF Limited提供服务

麥科醫藥-B待上市

18.200

0.000

成交量：- -

成交額：- -

市值：60.38億

市盈率：- -

高：- -

開：- -

低：- -

收：18.200

52周最高：- -

52周最低：- -

股本：3.32億

香港流通股本：2.74億

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：-33.11%

市淨率：-5.38

市盈率(LYR):- -

市銷率: 17847.04

1

开始申购

06/15

2

申購截止

06/18 10:15

3

公布中签

06/22

4

暗盘

06/23 16:15 - 18:30

5

挂牌上市

06/24

總覽公司新聞公告

新股消息 | 麥科醫藥-B(02335)招股結束孖展認購額錄得789億港元超購646倍

麥科醫藥6月24日上市，擬募資12億港元，目前零收入，年虧損1.85億元

深圳商报·读创

《新股情報》麥科醫藥(02335)今起招股入場費4242.36元

麥科醫藥-B(02335.HK)6月15日起招股發售價每股18.2-21.0港元

麥科醫藥-B今起招股募資逾10億港元，啓源香港、雲頂新耀等基石入局

麥科醫藥-B(02335)6月15-18日招股擬全球發售5805.44萬股H股

智通财经网

陝西麥科奧特醫藥全球發售：最高發售價21.0港元，擬發行逾5800萬股H股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02335/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02335","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","market":"HK","secType":"STK","nameCN":"麥科醫藥-B","latestPrice":18.2,"timestamp":1781769600000,"preClose":18.2,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":274000000,"shares":331740350,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"06-18 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.637,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1782264600000},"marketStatusCode":8,"adr":0,"listingDate":1782230400000,"exchange":"SEHK","adjPreClose":18.2,"openAndCloseTimeList":[[1781746200000,1781755200000],[1781758800000,1781769600000]],"volumeRatio":0,"ipoDetail":{"name":"麦科医药－Ｂ","exchange":"SEHK","listingDate":"2026-06-24","sharesOutstanding":331740350,"sharesFloat":331740350,"offerAmount":58054400,"priceRange":"18.200 - 21.000","market":"HK","openProspectusDate":"2026-06-15","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0615/2026061500010_c.pdf","purchaseBeginDate":"2026-06-15","purchaseEndDate":"2026-06-18","winningDate":"2026-06-23","currency":"HKD","minPurchaseQuantity":200,"peRate":-32.23,"use":"1、约39.1%或417.3百万港元，将用于核心产品的持续进行及计划的临床试验以及计划的商业推出；\n2、约36.3%或387.4百万港元，将用于关键产品的持续进行及计划的临床试验以及计划的商业推出；\n3、约14.6%或155.8百万港元，将用于其他候选产品及技术平台的研发；\n4、约10.0%或106.7百万港元，将用作营运资金及一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司为一家平台型生物技术公司，致力于加速全球新一代双特异性/多特异性多肽药物的创新及开发，公司的核心产品处于III期临床试验；作为提出双/多特异性肽技术概念的全球先驱，并凭借进入临床开发的广泛候选产品管线，公司已在该领域确立领先地位。","subscribed":663.28,"marketCap":6038000000,"minimumCapital":4242.36,"overAllotment":true,"lotSize":200,"issueOpenRate":0.1,"subscribeGear":"200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,2000000,2902800","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-06-23","greyDateTimestamp":1782144000000,"greyOpeningTime":1782202500000,"greyClosingTime":1782210600000,"showGreyQuote":false,"openProspectusDate":"2026-06-15","listingDate":"2026-06-24"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","floatShares":274000000,"roa":"-33.11%","roe":"--","lyrEps":0,"shares":331740350,"dividePrice":0,"high":0,"amplitude":0,"preClose":18.2,"low":0,"week52Low":0,"pbRate":"-5.38","psRate":"17847.04","week52High":0,"institutionHeld":0,"latestPrice":18.2,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.637,"open":0},"@#url:\"https://hktrade.skytigris.com/ipos/general/02335\",,undefined,":{"id":10148,"type":"COMMON","ipoName":"02335-IPO","symbol":"02335","companyName":"麥科醫藥-B","market":"HK","currency":"HKD","status":"CLOSED","underwriter":"建銀國際金融有限公司","lotSize":200,"minQty":200,"expectedOfferingSize":58054400,"openingDate":1781487000000,"closingDate":1781748900000,"commonClosingDate":1781748900000,"allotmentDate":1782057600000,"listDate":1782230400000,"marginable":true,"latestPrice":21,"minPrice":18.2,"maxPrice":21,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0615/2026061500010_c.pdf","allowedQuantities":[200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,2000000,2902800],"recommend":false,"isHint":false,"interestStartDate":1781712000000,"interestEndDate":1781971200000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1782202500000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[],"latestClosingDate":1782015869165,"subscribedFinanceRatio":663.28,"subscribedRatio":663.28,"forecastRatio":862.26,"raiseMoney":121920000,"totalMargin":80865900000,"quoteInfoUpdatedAt":1782015639450,"prospectusUpdatedAt":1781486891000,"forecastMarketValue":6502110860,"minForecastMarketValue":6037674370,"maxForecastMarketValue":6966547350,"sharesOutstanding":331740350,"business":"公司為一家平台型生物技術公司，致力於加速全球新一代雙特異性/多特異性多肽藥物的創新及開發，公司的核心產品處於III期臨床試驗；作為提出雙/多特異性肽技術概念的全球先驅，並憑藉進入臨床開發的廣泛候選產品管線，公司已在該領域確立領先地位。","greyOpeningTime":1782202500000,"greyClosingTime":1782210600000,"tradable":false,"showClawback":true,"clawbackType":"機制B","clawbackRate":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02335\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644772746","title":"新股消息 | 麥科醫藥-B(02335)招股結束 孖展認購額錄得789億港元 超購646倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2644772746","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644772746?lang=zh_tw&edition=fundamental","pubTime":"2026-06-18 14:08","pubTimestamp":1781762910,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物技术公司麦科医药-B于2026年6月15-2026年6月18日招股，最新已结束招股。根据市场消息，麦科医药已获券商借出约789亿港元孖展，以公开发售集资额1.22亿港元计算，超购646倍。麦科医药拟全球发售5805.44万股H股，香港公开发售580.56万股，国际发售5224.88万股，另有15%超额配股权。本次IPO，麦科医药引入启源香港、云顶新耀和顺鸣资本为基石投资者，投资金额总共约4.49亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643979738","title":"麥科醫藥6月24日上市，擬募資12億港元，目前零收入，年虧損1.85億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643979738","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643979738?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 10:35","pubTimestamp":1781577323,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端记者李薇陕西麦科奥特医药科技股份有限公司（简称“麦科医药”，股票代码：“02335”）日前开启路演，准备2026年6月24日在港交所上市。麦科医药发行区间为18.2港元到21港元，拟全球发售5805.44万股，最高募资12.19亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606163772750150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IPOS","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643228478","title":"《新股情報》麥科醫藥(02335)今起招股 入場費4242.36元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643228478","media":"汇港资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643228478?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 07:29","pubTimestamp":1781479740,"startTime":"0","endTime":"0","summary":"<汇港通讯>生物技术公司麦科医药-B今日起招股，招股详情如下:发售股数：5805.44万股H股，其中5224.88万股(90%)为国际发售，580.56万股(10%)为香港发售，另有15%超额配股权。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"infocastfn_hk_stock","url":"https://www.infocastfn.com//fn/ajax/news/newsDetail?newsId=4923929","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.infocastfn.com//fn/ajax/news/newsDetail?newsId=4923929","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"infocastfn_hk_stock","symbols":["02335","BK1574","BK1161","BK1515","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643422897","title":"麥科醫藥-B(02335.HK)6月15日起招股 發售價每股18.2-21.0港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643422897","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643422897?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 07:17","pubTimestamp":1781479021,"startTime":"0","endTime":"0","summary":"　　格隆汇6月15日丨麦科医药-B(02335.HK)发布公告，公司拟全球发售5805.44万股H股(视乎超额配股权行使与否而定)，中国香港发售580.56万股H股(可予重新分配)，国际发售5224.88万股H股(可予重新分配及视乎超额配股权行使与否而定)；2026年6月15日至6月18日招股；发售价将为每股发售股份18.2港元-21.0港元，H股的每手买卖单位将为200股，建银国际及$招商证券(600999)$国际为联席保荐人；预期H股将于2026年6月24日开始于联交所买卖。\n\n　　 ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260615/32279144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159938","02335","BK1574","EWH","BK1515","IPOS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643422884","title":"麥科醫藥-B今起招股募資逾10億港元，啓源香港、雲頂新耀等基石入局","url":"https://stock-news.laohu8.com/highlight/detail?id=2643422884","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643422884?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 07:15","pubTimestamp":1781478906,"startTime":"0","endTime":"0","summary":"6月15日，麦科医药-B于2026年6月15-2026年6月18日招股，拟全球发售5805.44万股H股，香港公开发售580.56万股，国际发售5224.88万股，另有15%超额配股权。此外，公司已与启源香港、$云顶新耀$及顺鸣资本订立基石投资协议，基石投资者已同意在若干条件的规限下认购总金额为约4.49亿港元的发售股份。预计公司的MT1013将于2028年初商业化，公司将实行双轨商业化策略：在国内透过与第三方合约销售组织合作，在国际上则透过授权合作伙伴关系。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454121.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","IPOS","02335","159938","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643472240","title":"麥科醫藥-B(02335)6月15-18日招股 擬全球發售5805.44萬股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643472240","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643472240?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 06:26","pubTimestamp":1781476012,"startTime":"0","endTime":"0","summary":"麦科医药-B(02335)于2026年6月15-2026年6月18日招股，拟全球发售5805.44万股H股，香港公开发售580.56万股（可与重新分配），国际发售5224.88万股（可与重新分配），另有15%超额配股权。每股发售价18.2-21港元，每手200股，预期H股将于2026年6月24日(星期三)上午九时正开始在联交所买卖。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_18.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_18.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IPOS","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188646971","title":"陝西麥科奧特醫藥全球發售：最高發售價21.0港元，擬發行逾5800萬股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1188646971","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188646971?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 06:23","pubTimestamp":1781475782,"startTime":"0","endTime":"0","summary":"陕西麦科奥特医药科技股份有限公司是一家专注于肾脏代谢性疾病、心血管和内分泌等领域创新疗法的生物技术公司，核心产品和多条管线仍处于临床试验或研发阶段，尚未实现核心产品商业化，当前主要收入来源为其他收益。本次发行假设以每股19.60港元计，扣除相关费用后预计可募资约10.67亿港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"陕西麦科奥特医药全球发售：最高发售价21.0港元，拟发行逾5800万股H股","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}